Conor Barry
VP Bioconjugates & Biologics Piramal Pharma Solutions
Seminars
Tuesday 4th November 2025
Evaluating Phase & Product Appropriate Bioconjugate Development
12:30 pm
- Exploring the differing development approaches of ADCs across the preclinical to commercial spectrum
- Understanding how the bioconjugate landscape now encompasses a wide variety of modalities with differing mechanisms of action and molecular structures
- Exploring relevant examples of how the requirements for process and analytical development can vary between different conjugates
